Antibodies - The "Magic Bullets" for Drug Delivery?

Efforts to develop clinically effective cell-specific drug-delivery technology have not as yet been successful. This prospective review gives and analyzes reasons for the lack of progress in this area, and argues that the use of antibodies as drug carriers offers the best currently available approach. For this approach to work, drugs to be delivered must exhibit the pharmacokinetic properties matching the essential requirements of cellspecific drug delivery. Examples from targeting cancer drugs are used.

Author(s): Karel Petrak

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs


tempobet giriş

tempobet giriş

tipobet süpertotobet yeni adres süperbahis 747 güvenilir bahis siteleri telefonda sex sohbet